Introduction
Author:
Liu Sumei,Zhu Jin-Xia
Publisher
Springer Singapore
Reference89 articles.
1. Abrantes Dias AS, Amaral Pinto JC, Magalhaes M, Mendes VM, Manadas B (2020) Analytical methods to monitor dopamine metabolism in plasma: moving forward with improved diagnosis and treatment of neurological disorders. J Pharm Biomed Anal 187:113323. https://doi.org/10.1016/j.jpba.2020.113323
2. Agid Y, Javoy F, Youdim MB (1973) Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway. Br J Pharmacol 48(1):175–178. https://doi.org/10.1111/j.1476-5381.1973.tb08238.x
3. Aguilar MJ, Estan L, Martinez-Mir I, Martinez-Abad M, Rubio E, Morales-Olivas FJ (2005) Effects of dopamine in isolated rat colon strips. Can J Physiol Pharmacol 83(6):447–452. https://doi.org/10.1139/y05-031
4. Amenta F, Ferrante F, Ricci A (1995) Pharmacological characterisation and autoradiographic localisation of dopamine receptor subtypes in the cardiovascular system and in the kidney. Hypertens Res 18(Suppl 1):S23–S27. https://doi.org/10.1291/hypres.18.supplementi_s23
5. Aperia AC (2000) Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62:621–647. https://doi.org/10.1146/annurev.physiol.62.1.621